ClinicalTrials.Veeva

Menu

Quality of Life in Patients With Double Loop Ureteral Stent (JJ Silicone Hydrogel Study)

Coloplast logo

Coloplast

Status and phase

Unknown
Phase 4

Conditions

Kidney Calculi

Treatments

Device: Double Loop Ureteral stent endoscopic placement.

Study type

Interventional

Funder types

Industry

Identifiers

NCT02489656
DUDLUIV1201EC

Details and patient eligibility

About

This study is a prospective, randomized multicenter study conducted in Europe. It is designed to compare two double loop ureteral stents in terms of the quality of life in patients operated on a kidney stone and requiring the placement of a double loop ureteral stent at the end of the operation.

Full description

  • The double loop stents are used for both prevention and treatment of ureteral obstruction: They permit the interim internal bypass drainage of urine when obstruction in the ureter especially in cases of lithiasis or after surgical intervention on the upper urinary tract.

  • There are many indications for double loop stent placement and population chosen for this study are adult patients with intra-renal calcium calculi of 7-20 mm in diameter for whom the treatment indication is a flexible ureterorenoscopy.

  • The aims of the use of a double loop stent are to

    • prevent complications (pain, infection) associated with the ureteral obstruction by any residual stone fragments, blood clot or local oedema generated by the intervention.
    • preserve the renal function.
    • facilitate healing process while limiting the risk of stenosis and probably reduce the rate of readmission after patients' discharge.
  • Double loop Stent-related symptoms have a high prevalence and may affect over 80% of patients.

  • Assessment tools are important to determine the symptoms intensity and allow for comparisons at different times. The Urinary Stent Symptom Questionnaire (USSQ) is the most adapted tool designed for this purpose.

  • An ideal ureteral stent is expected to drain well, to be easy to insert and to be comfortable for the patients. The investigators designed a hydro-coated Silicone JJ stent with additional properties for improving patient's comfort.

  • The investigators decided to perform a randomized clinical investigation to evaluate the Coloplast Hydrocoated Silicone JJ in comparison to the Boston Percuflex Plus JJ stent on patients' comfort.

Enrollment

140 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male and female patients
  2. Aged > 18 years
  3. Unilateral renal non-infection stone for whom the treatment indication is a flexible ureterorenoscopy (multiple kidney stones are acceptable provided that only one side is currently symptomatic)
  4. Index stone of 5-25 mm (measured on plain abdomen X-Ray KUB or CT)
  5. Without any currently implanted JJ stent
  6. Patient agreed to participate to the study and having signed the consent form
  7. Able to complete self-rated questionnaires.

Exclusion criteria

  1. Acute ureteric/nephritic colic (residual pain is acceptable)
  2. Any type of chronic pain
  3. Large stones > 25 mm
  4. Infection renal stone already diagnosed and documented
  5. Malformation of urinary tract (e.g. Horseshoe kidney, duplicity or, ureterocele, mega ureter)
  6. Diverticulum stone
  7. Urogenital tumor
  8. Any significant neurological disease or injury impacting sensation
  9. JJ stents already implanted
  10. Patients with long-term indwelling urethral catheter
  11. No indication for JJ insertion (e.g. spontaneous stone passage)
  12. Untreated urinary tract infection
  13. Ureteral obstruction (stenosis, compression, calculi)
  14. Neurogenic bladder
  15. Overactive bladder
  16. Bladder stone
  17. Chronic prostatitis
  18. BPH treated (recent initiation of 5 alpha-Reductase Inhibitor or Phytotherapeutic agents)
  19. Ongoing Alpha-Blocker or Anticholinergic medication
  20. Pregnancy
  21. Any event discovered during the endoscopy which is not compatible with the study design and objective

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

140 participants in 2 patient groups

Coloplast Hydrocoated silicone JJ stent
Experimental group
Description:
Double loop ureteral stent endoscopic placement
Treatment:
Device: Double Loop Ureteral stent endoscopic placement.
Boston Percuflex Plus JJ stent
Active Comparator group
Description:
Double loop ureteral stent endoscopic placement
Treatment:
Device: Double Loop Ureteral stent endoscopic placement.

Trial contacts and locations

1

Loading...

Central trial contact

Dorothee Behr, Med Manager; Pascale HS Holliday, CTM

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems